ℹ️ Compiled from public regulatory records · Last regulator revision: December 17, 2024🚩 Report this page
Folate
Active ingredient
Sold as Menatrol · Folixate · Livita Children
US FDA
- Drug class
- -
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 3
- FDA reports (12 mo)
- 2
Overview
Folate is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | December 17, 2024 |
USUnited States· FDA
3 products
Uses
INDICATIONS AND USAGE
Folixate ™ is indicated for dietary management of patients with unique nutritional needs requiring increased folate level and Vitamin D supplementation. Folixate™ can be taken by women of childbearing age, pregnant women, and lactating and nonlactating mothers.
How to take
Sources & citations
- [1]FDA DailyMed · 0bb91f61-b61b-c8… · revised December 5, 2023 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.